188 related articles for article (PubMed ID: 31963684)
1. The Preparation of Ginsenoside Rg5, Its Antitumor Activity against Breast Cancer Cells and Its Targeting of PI3K.
Liu Y; Fan D
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963684
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model.
Liu Y; Fan D
Food Funct; 2018 Nov; 9(11):5513-5527. PubMed ID: 30207362
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg5 induces NSCLC cell apoptosis and autophagy through PI3K/Akt/mTOR signaling pathway.
Zhang C; Jin Y
Hum Exp Toxicol; 2024; 43():9603271241229140. PubMed ID: 38289222
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg5 induces apoptosis in human esophageal cancer cells through the phosphoinositide‑3 kinase/protein kinase B signaling pathway.
Zhang D; Wang A; Feng J; Zhang Q; Liu L; Ren H
Mol Med Rep; 2019 May; 19(5):4019-4026. PubMed ID: 30942438
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg5 Inhibits Human Osteosarcoma Cell Proliferation and Induces Cell Apoptosis through PI3K/Akt/mTORC1-Related LC3 Autophagy Pathway.
Liu MY; Liu F; Li YJ; Yin JN; Gao YL; Wang XY; Yang C; Liu JG; Li HJ
Oxid Med Cell Longev; 2021; 2021():5040326. PubMed ID: 34257801
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.
Hong Y; Fan D
Toxicology; 2019 Apr; 418():22-31. PubMed ID: 30797898
[TBL] [Abstract][Full Text] [Related]
7. Ginsenosides Inhibit the Proliferation of Lung Cancer Cells and Suppress the Rate of Metastasis by Modulating EGFR/VEGF Signaling Pathways.
Yu X; Wang Q; Dai Z
J Oleo Sci; 2024; 73(2):219-230. PubMed ID: 38311411
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg5 induces G2/M phase arrest, apoptosis and autophagy via regulating ROS-mediated MAPK pathways against human gastric cancer.
Liu Y; Fan D
Biochem Pharmacol; 2019 Oct; 168():285-304. PubMed ID: 31301277
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells.
Ji Y; Di W; Yang Q; Lu Z; Cai W; Wu J
Clin Lab; 2015; 61(8):1043-51. PubMed ID: 26427150
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside-Rg5 Inhibits Retinoblastoma Proliferation and Induces Apoptosis through Suppressing BCL2 Expression.
Cui Y; Su Y; Deng L; Wang W
Chemotherapy; 2018; 63(5):293-300. PubMed ID: 30731458
[TBL] [Abstract][Full Text] [Related]
11. The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway.
Liu H; Zhao J; Fu R; Zhu C; Fan D
PLoS One; 2019; 14(5):e0216759. PubMed ID: 31091245
[TBL] [Abstract][Full Text] [Related]
12. Targeted antitumor activity of Ginsenoside (Rg1) in paclitaxel-resistant human nasopharyngeal cancer cells are mediated through activation of autophagic cell death, cell apoptosis, endogenous ROS production, S phase cell cycle arrest and inhibition of m-TOR/PI3K/AKT signalling pathway.
Li W; Li G; She W; Hu X; Wu X
J BUON; 2019; 24(5):2056-2061. PubMed ID: 31786875
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rb1 mitigates oxidative stress and apoptosis induced by methylglyoxal in SH-SY5Y cells via the PI3K/Akt pathway.
Nan F; Sun G; Xie W; Ye T; Sun X; Zhou P; Dong X; Sun J; Sun X; Zhang M
Mol Cell Probes; 2019 Dec; 48():101469. PubMed ID: 31629029
[TBL] [Abstract][Full Text] [Related]
14. The Anti-Tumor Effect and Underlying Apoptotic Mechanism of Ginsenoside Rk1 and Rg5 in Human Liver Cancer Cells.
Chen C; Lv Q; Li Y; Jin YH
Molecules; 2021 Jun; 26(13):. PubMed ID: 34199025
[TBL] [Abstract][Full Text] [Related]
15. Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo.
Dong Y; Fu R; Yang J; Ma P; Liang L; Mi Y; Fan D
Int J Nanomedicine; 2019; 14():6971-6988. PubMed ID: 31507319
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.
Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y
Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg5 attenuates hypoxia-induced cardiomyocyte apoptosis via regulating the Akt pathway.
Wang C; Huang C; Wang J; Ye J; Xue Z; Zhang J; Ren Y
Chem Biol Drug Des; 2023 Jun; 101(6):1348-1355. PubMed ID: 36762503
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
Yuan Z; Jiang H; Zhu X; Liu X; Li J
Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z
Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study.
Jabbarzadeh Kaboli P; Leong MP; Ismail P; Ling KH
Pharmacol Rep; 2019 Feb; 71(1):13-23. PubMed ID: 30343043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
